ArticleHaematologica2013

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.

Anne-Kathrin Hechinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.